Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-3628

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-3628). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc,, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3628 9)

Label for Atorvastatin Calcium 40 mg film-coated tablets by NuCare Pharmaceuticals, Inc. The label indicates a quantity of 90 tablets in the package. It includes the NDC 68071-3628-9 and states it is Rx only. Additional labeling details show manufacturing and packaging by Amnora Pharma Pvt. Ltd., Telangana, India, and storage instructions to keep at 68-77°F. Various barcode and serial number information appear, along with caution to keep out of reach of children.*

FDA Label Image

Atorvastatinfigure1. (Atorvastatinfigure1)

Chemical structure diagram of Atorvastatin Calcium, showing its molecular formula including calcium ions and water molecules, consistent with the active ingredient Atorvastatin Calcium.*

FDA Label Image

Atorvastatinfigure2. (Atorvastatinfigure2)

A line graph showing cumulative incidence (%) over time in years for two groups labeled Atorvastatin and Placebo. The Atorvastatin group shows a consistently lower cumulative incidence compared to Placebo. The graph includes a hazard ratio (HR=0.54) with a confidence interval (2.50-0.83) and a p-value of 0.0005.*

FDA Label Image

Atorvastatinfigure3. (Atorvastatinfigure3)

A line graph comparing cumulative hazard percentages between Placebo and Atorvastatin over a 5-year follow-up period. The x-axis represents time to first primary endpoint through four years of follow-up (years), and the y-axis shows cumulative hazard percentage. The graph includes hazard ratio (HR) and p-value data indicating statistical significance.*

FDA Label Image

Atorvastatinfigure4. (Atorvastatinfigure4)

A line graph comparing time to first major cardiovascular endpoint over 5 years for Atorvastatin 10 mg and 80 mg. The Y-axis shows the proportion of subjects experiencing the event, with lower incidence for Atorvastatin 80 mg. Statistical data includes a hazard ratio of 0.78 with confidence interval and p-value.*

FDA Label Image

Atorvastatinfigure9 (Atorvastatinfigure9)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.